Literature DB >> 8259095

What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?

C Labreveux de Cervens1, O Hartmann, F Bonnin, D Couanet, D Valteau-Couanet, J Lumbroso, C Behar, H Martelli, J Lemerele.   

Abstract

Twenty-seven infants under one year of age with metastatic neuroblastoma were studied for osteomedullary metastases. They were evaluated by at least two imaging procedures: X-ray films and MIBG scan. Taking into account the results of these investigations, 3 groups were defined: osteomedullary metastases were detected in 8 infants by both X-ray and MIBG scan, no osteomedullary sites were detected by either technique in 13 patients, and 6 had osteomedullary foci with positive MIBG uptake but no radiological abnormality. These three groups were apparently different in terms of median age, response to chemotherapy, and long-term survival. The third group, which has not been previously described, appears to have a better prognosis than patients with radiologically detectable bone lesions. Nevertheless it was necessary to use intensive chemotherapy to obtain remission in these particular patients. It should be mandatory to specify the investigatory technique used to describe osteomedullary metastases in infants and treatment should be adapted according to this grouping system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259095     DOI: 10.1002/mpo.2950220209

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

Review 1.  Norepinephrine Transporter as a Target for Imaging and Therapy.

Authors:  Neeta Pandit-Taskar; Shakeel Modak
Journal:  J Nucl Med       Date:  2017-09       Impact factor: 10.057

Review 2.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

Review 3.  Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.

Authors:  Jia Xia; Hang Zhang; Qun Hu; Shuang-You Liu; Liu-Qing Zhang; Ai Zhang; Xiao-Ling Zhang; Ya-Qin Wang; Ai-Guo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

4.  Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.

Authors:  V Minard; O Hartmann; M C Peyroulet; J Michon; C Coze; A S Defachelle; O Lejars; Y Perel; C Bergeron; P Boutard; G Leverger; J L Stephan; A Thyss; P Chastagner; G Couillault; C Devalck; P Lutz; F Mechinaud; F Millot; D Plantaz; X Rialland; H Rubie
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.